IQVIA Holdings (MIL:1IQV) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1IQV IQVIA Holdings Inc MIL:1IQV
67 GF Score
Price €184.25
GF Value €221.81
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is IQVIA Holdings Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

MIL:1IQV
67GF Score
IQVIA Holdings Inc MIL:1IQV
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is IQVIA Holdings (MIL:1IQV) Overvalued in 2026?

Based on GuruFocus' analysis, IQVIA Holdings stock appears to be undervalued. The current stock price of €184.25 is trading 16.9% below its estimated GF Value™ of €221.81. GuruFocus considers IQVIA Holdings to be Modestly Undervalued.

Key valuation signals for MIL:1IQV:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €221.81 vs. price of €184.25 (16.9% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the MIL:1IQV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IQVIA Holdings Business Description

Address 2400 Ellis Road, Durham, NC, USA, 27703
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
67GF Score

Get the complete analysis for MIL:1IQV

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€184.25
Price
€221.81
GF Value